October 28, 2024—Cambridge, MA, and Bordeaux, France—inHEART, a medical device company delivering the world’s most advanced, AI-driven digital twin of the heart, announced that it has successfully closed a 750k€ funding round with SWEN Capital Partners, through its VC Tech for Good strategy. This strategic investment highlights the continued confidence in inHEART’s innovative technology and mission to transform the treatment of cardiac arrhythmias through advanced 3D imaging solutions.
‍

The funding from SWEN Capital Partners will enable inHEART to accelerate the development of its cutting-edge imaging platform, designed to improve precision in diagnosing and treating complex heart rhythm disorders. It will also help inHEART expand its reach and enhance its ability to provide life-changing technology to healthcare professionals and patients worldwide.
‍

Todor Jeliaskov, Chairman & CEO of inHEART, commented: "We are thrilled to receive this support from SWEN Capital Partners. Their belief in our vision and technology will be instrumental in furthering our mission to improve the outcomes of cardiac arrhythmia treatments. This investment is a significant milestone for us, allowing inHEART to continue driving innovation in healthcare"
‍

“We are delighted to be collaborating with inHEART to transform the management of cardiac arrhythmias through innovative medical imaging solutions,” says Xavier Le Blan, Head of Innovation & Wealth Management at SWEN Capital Partners. “This collaboration allows us to push the boundaries of precision medicine, delivering more targeted and personalized care to patients.”
‍

We extend our sincere gratitude to SWEN Capital Partners for their trust in our team and technology. We look forward to leveraging this investment to make meaningful progress in cardiac care.

‍

About inHEART

inHEART is delivering the world’s first AI-driven, digital twin of the heart to advance the care of patients living with cardiac disease. We are committed to addressing the needs of the cardiac care continuum by providing personalized therapy in a predictive manner for screening and early detection of cardiac diseases. At inHEART, we believe that all patients deserve access to world-class cardiac imaging expertise to optimize treatment strategies, improve clinical outcomes, and return patients to full, healthy lives. For more information, visit inheartmedical.com
‍

About SWEN Capital Partners

Founded in 2008, SWEN Capital Partners is a leading European asset management firm specializing in sustainable investment strategies, with a strong focus on supporting innovative companies in the healthcare and technology sectors.